0002038992-25-000002.txt : 20251021 0002038992-25-000002.hdr.sgml : 20251021 20251021120919 ACCESSION NUMBER: 0002038992-25-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20251021 DATE AS OF CHANGE: 20251021 EFFECTIVENESS DATE: 20251021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Larx Apex LP CENTRAL INDEX KEY: 0002038992 ORGANIZATION NAME: EIN: 661077490 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-525190 FILM NUMBER: 251405974 BUSINESS ADDRESS: STREET 1: 53 CALLE PALMERAS STREET 2: SUITE 601 CITY: SAN JUAN STATE: PR ZIP: 00901 BUSINESS PHONE: 786-505-8788 MAIL ADDRESS: STREET 1: 53 CALLE PALMERAS STREET 2: SUITE 601 CITY: SAN JUAN STATE: PR ZIP: 00901 D/A 1 primary_doc.xml X0708 D/A LIVE 0002038992 Larx Apex LP 53 CALLE PALMERAS SUITE 601 SAN JUAN PR PUERTO RICO 00901 786-505-8788 DELAWARE None None Limited Partnership true 2024 Brandon A Spruill 53 Calle Palmeras Suite 601 San Juan PR PUERTO RICO 00901 Executive Officer Pooled Investment Fund Hedge Fund false No Aggregate Net Asset Value 06b 3C 3C.1 true 0002038992-24-000001 2024-10-01 true true false 250000 Indefinite 4134057 Indefinite false 4 0 0 0 false Larx Apex LP Brandon Spruill Brandon Spruill Managing Partner, General Partner 2025-10-21